A detailed history of Becker Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Becker Capital Management Inc holds 10,475 shares of ABT stock, worth $1.35 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
10,475
Previous 9,452 10.82%
Holding current value
$1.35 Million
Previous $982,000 21.59%
% of portfolio
0.04%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$100.07 - $118.13 $102,371 - $120,846
1,023 Added 10.82%
10,475 $1.19 Million
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $28,506 - $31,820
-283 Reduced 2.91%
9,452 $982,000
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $118,062 - $130,394
-1,078 Reduced 9.97%
9,735 $1.11 Million
Q4 2023

Feb 14, 2024

BUY
$90.19 - $110.4 $3,066 - $3,753
34 Added 0.32%
10,813 $1.19 Million
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $23,786 - $28,540
-249 Reduced 2.26%
10,779 $1.04 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $3,325 - $3,705
-33 Reduced 0.3%
11,028 $1.2 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $12,785 - $15,049
132 Added 1.21%
11,061 $1.12 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $14,354 - $16,839
151 Added 1.4%
10,929 $1.2 Million
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $2,322 - $2,688
-24 Reduced 0.22%
10,778 $1.04 Million
Q2 2022

Aug 04, 2022

BUY
$102.07 - $123.37 $266,606 - $322,242
2,612 Added 31.89%
10,802 $1.17 Million
Q1 2022

May 12, 2022

SELL
$114.02 - $139.04 $7,411 - $9,037
-65 Reduced 0.79%
8,190 $969,000
Q4 2021

Feb 08, 2022

SELL
$115.53 - $141.46 $66,545 - $81,480
-576 Reduced 6.52%
8,255 $1.16 Million
Q3 2021

Oct 14, 2021

SELL
$116.66 - $129.06 $13,765 - $15,229
-118 Reduced 1.32%
8,831 $1.04 Million
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $52,471 - $61,766
496 Added 5.87%
8,949 $1.04 Million
Q1 2021

May 13, 2021

SELL
$108.84 - $128.23 $5,333 - $6,283
-49 Reduced 0.58%
8,453 $1.01 Million
Q4 2020

Feb 10, 2021

SELL
$105.0 - $114.42 $2,310 - $2,517
-22 Reduced 0.26%
8,502 $931,000
Q3 2020

Nov 09, 2020

SELL
$91.64 - $111.29 $10,813 - $13,132
-118 Reduced 1.37%
8,524 $928,000
Q2 2020

Aug 11, 2020

SELL
$76.57 - $98.0 $20,214 - $25,872
-264 Reduced 2.96%
8,642 $790,000
Q4 2019

Feb 11, 2020

SELL
$78.51 - $87.4 $2,747 - $3,059
-35 Reduced 0.39%
8,906 $774,000
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $93,379 - $101,252
-1,141 Reduced 11.32%
8,941 $748,000
Q2 2019

Aug 08, 2019

SELL
$72.88 - $85.0 $1,822 - $2,125
-25 Reduced 0.25%
10,082 $848,000
Q1 2019

May 08, 2019

BUY
$66.22 - $80.06 $7,946 - $9,607
120 Added 1.2%
10,107 $808,000
Q3 2018

Nov 05, 2018

SELL
$60.81 - $73.36 $193,679 - $233,651
-3,185 Reduced 24.18%
9,987 $733,000
Q2 2018

Aug 03, 2018

SELL
$57.57 - $63.54 $8,635 - $9,531
-150 Reduced 1.13%
13,172 $803,000
Q1 2018

May 07, 2018

SELL
$56.27 - $63.62 $19,581 - $22,139
-348 Reduced 2.55%
13,322 $798,000
Q4 2017

Feb 13, 2018

SELL
$53.68 - $57.47 $8,481 - $9,080
-158 Reduced 1.14%
13,670 $780,000
Q3 2017

Nov 02, 2017

BUY
$48.06 - $53.64 $23,309 - $26,015
485 Added 3.63%
13,828 $738,000
Q2 2017

Aug 11, 2017

BUY
N/A
13,343
13,343 $649,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $226B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Becker Capital Management Inc Portfolio

Follow Becker Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Becker Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Becker Capital Management Inc with notifications on news.